Efficacy Study for the Symptomatic Treatment of Chronic Idiopathic Urticaria

NCT00421109 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

522

Enrollment

INDUSTRY

Sponsor class

Conditions

Urticaria

Interventions

DRUG: Bilastine
DRUG: Levocetirizine
DRUG: Placebo

Sponsor

Faes Farma, S.A.